Joshua Budhu, Neuro-Oncologist at Memorial Sloan Kettering Cancer Center, shared a post on LinkedIn about a paper he co-authored:
“Thrilled to share our recently published review in Seminars in Neurology: Imaging in Neuro-oncology
Imaging remains the foundation of care for patients with primary and metastatic brain tumors.
In this article, we outline:
- Core MRI sequences every neurologist should know
- Advanced modalities: perfusion imaging, susceptibility-weighted imaging, delayed contrast, diffusion tensor imaging, and MR spectroscopy
- The growing role of amino acid PET and emerging tracers
- Updated RANO 2.0 and PET-RANO response criteria
- Innovations in radiomics and artificial intelligence
- Challenges and opportunities to ensure equitable access to advanced imaging
Our goal was to provide a practical, clinically focused guide for neurologists and trainees as neuro-imaging becomes increasingly sophisticated and integral to precision neuro-oncology. ”
Title: Imaging in Neuro-oncology
Authors: Elizabeth Coffee, Cleopatra Elshiekh, Joshua A. Budhu
Read the full article on Seminars in Neurology.
More posts featuring Neuro-Oncology on OncoDaily.
